Sign in
4/A

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-053346

Director bought 55,555 shares at $18.00 ($999,990)

  • Director acquired 6,414,356 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ORONSKY ARNOLD L Director 2020-09-25 Purchase +55,555 $18.00 $999,990 55,555 I: show line 1 in the form
ORONSKY ARNOLD L Director 2020-09-29 Conversion +1,620,101 1,675,656 I: show line 2 in the form
ORONSKY ARNOLD L Director 2020-09-29 Conversion +3,488,398 5,164,054 I: show line 3 in the form
ORONSKY ARNOLD L Director 2020-09-29 Conversion +1,040,654 6,204,708 I: show line 4 in the form
ORONSKY ARNOLD L Director 2020-09-29 Conversion +265,203 6,469,911 I: show line 5 in the form
Open-market purchases · 55,555 sh · avg $18.00 · $999,990

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ORONSKY ARNOLD L Director 2020-09-29 Conversion · Series Seed Preferred Stock −1,620,101 0 I: show line 6 in the form
ORONSKY ARNOLD L Director 2020-09-29 Conversion · Series A Preferred Stock −3,488,398 0 I: show line 7 in the form
ORONSKY ARNOLD L Director 2020-09-29 Conversion · Series B Preferred Stock −1,040,654 0 I: show line 8 in the form
ORONSKY ARNOLD L Director 2020-09-29 Conversion · Series C Preferred Stock −265,203 0 I: show line 9 in the form
Loading xslF345X03/doc4a.xml…